Form 4 for SOPH SOPHiA GENETICS SA
Accepted 2026-04-01 10:41:47 ET · period of report 2026-03-31 · accession 0001840706-26-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 10:41 | 2026-03-31 | SOPH | Puylaert Kevin | Chief Sales Off | S - Sale | $4.71 | -3 | 92.4K | -0.0% | -$14.13 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-31 | S | D | 3 | $4.71 | 92,383 | D | — | — | (F1) Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on March 30, 2026. The sales were effected as a "sell to cover" transaction and do not represent discretionary trades. |